Back to results
US 2006/0148723 A1Published application
Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient
AssigneeJapan as Represented by President of National Center of Neurology and Psychiatry
InventorsTakashi Yamamura, Sachiko Miyake
Life of this patent
Estimating the term…
Abstract
The invention is a glycolipid useful in treating autoimmune diseases and a medicine thereof as active ingredient for autoimmune diseases, wherein R1 is an aldopyranose group, R2 is a hydrogen atom or a hydroxyl group, R3 is —CH2—, —CH(OH)—CH2— or —CH═CH—, R4 is a hydrogen atom or CH3, x is 0-35, y and z represent integers satisfying y+z=0-3.
Claims19
A glycolipid represented by the formula below (I).
- wherein, R1 is an aldopyranose group, R2 is a hydrogen atom or a hydroxyl group, R3 is —CH2—, —CH(OH)—CH2— or —CH═CH—, R4 is a hydrogen atom or CH3, x is 0-35, y and z represent integers satisfying y+z=0-3.
5-8. (canceled)
Dependencies are inferred from the claim text.